NCT07905404: Suzetrigine (Journavx) as Multimodal Therapy for Pain Management in Adults Undergoing Surgery for Hip Fracture
- State
- Not started
- Phase
- Phase 4
- People
- 79 planned
- Started
- 5 Jan 2027
- Primary completion
- 30 Jul 2028
- Arms
- Suzetrigine + Standard Multimodal Analgesia
- Results
- None posted
- 29 Oct 2026: Trial registered